Bausch Health
BHC
6.15
+0.13
+2.16%
Bausch Health
US · BHC
#2722 by market cap
Listed 1970
6.15
+0.13
+2.16%
Live - 5344 symbols - heartbeat 56s ago
· 2026-10-08 06:55
Pre-market
5.60
-8.92%
After-hours
6.15
0.00%
- Market cap
- 2.30B
- P/E (TTM)i
- -2.09
- P/Bi
- -1.30
- EPSi
- 0.42
- Div yieldi
- 0.00%
- 52W posi
- 50%
Reader sentiment
Are you bullish or bearish on BHC?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Distributing
- The number of reporting institutions increased by 1 in the most recent period (2026/Q3).
- Total institutional ownership fell 0.4 percentage points.
Institutional ownership
- Held by institutions
- 65.57% -0.39pp
- Institutions
- 254 +1
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
AlignedInstitutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Hedge Fund37.16%
Mutual Fund16.00%
Individual/Insider10.73%
Public Company5.45%
Government Pension Fund2.55%
Private Company1.98%
VC/PE Fund1.40%
Sovereign Wealth Fund0.93%
Other23.72%
Top holders as of 2026-06-30
Paulson & Co. Inc.
19.59% · 73.26M sh
Alexander Meruelo
9.77% · 36.54M sh
GoldenTree Asset Management LP
9.27% · 34.67M sh
Vanguard Capital Management, LLC
2.60% · 9.72M sh
Healthcare of Ontario Pension Plan Trust Fund
2.14% · 8.00M sh
The Goldman Sachs Group, Inc.
1.62% · 6.07M sh
MFN Partners Management, LP
1.60% · 6.00M sh
SG Americas Securities, LLC
1.48% · 5.54M sh
Acadian Asset Management LLC
1.47% · 5.48M sh
KKR & Co. Inc.
1.40% · 5.24M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 31 buys · 19 sells
| Name | Role | Stake |
|---|---|---|
| Paulson & Co. Inc. | -- | 19.59% |
| Thomas Appio | Chief Executive Officer | 0.23% |
| Seana Carson | Executive Vice President | 0.19% |
| Jean-Jacques Charhon | Chief Financial Officer | 0.05% |
| Amy Wechsler | Independent Director | 0.03% |
| Christian Garcia | Independent Director | 0.02% |
| Sandra Leung | Corporate Director | 0.01% |
| Frank Lee | Independent Director | 0.01% |
| Aimee Lenar | Executive Vice President of US Pharma | 0.01% |
| Robert Power | Independent Director | 0.00% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-29 | Sandra Leung | Corporate Director | Other Acquisition | +5,789 | $5.83 |
| 2026-09-29 | John Paulson | Independent Chairperson | Other Acquisition | +10,720 | $5.83 |
| 2026-09-29 | Amy Wechsler | Independent Director | Other Acquisition | +1,179 | $5.83 |
| 2026-08-18 | Aimee Lenar | Executive Vice President of US Pharma | Automatic Disposition | -36,827 | $7.03 |
| 2026-07-16 | Aimee Lenar | Executive Vice President of US Pharma | Sale to Issuer | -5,260 | $4.83 |
| 2026-07-14 | Aimee Lenar | Executive Vice President of US Pharma | Sale to Issuer | -23,395 | $4.89 |
| 2026-07-13 | Steven Lee | -- | Sale to Issuer | -3,125 | $4.75 |
| 2026-06-29 | Sandra Leung | Corporate Director | Other Acquisition | +6,845 | $4.93 |
| 2026-06-29 | John Paulson | Independent Chairperson | Other Acquisition | +12,677 | $4.93 |
| 2026-06-29 | Amy Wechsler | Independent Director | Other Acquisition | +1,394 | $4.93 |
| 2026-05-21 | Sandra Leung | Corporate Director | Other Acquisition | +45,871 | -- |
| 2026-05-21 | John Paulson | Independent Chairperson | Other Acquisition | +45,871 | -- |
| 2026-05-21 | Robert Power | Independent Director | Other Acquisition | +45,871 | -- |
| 2026-05-21 | Sarah Kavanagh | Independent Director | Other Acquisition | +45,871 | -- |
| 2026-05-21 | Christian Garcia | Independent Director | Other Acquisition | +45,871 | -- |
| 2026-05-21 | Amy Wechsler | Independent Director | Other Acquisition | +45,871 | -- |
| 2026-05-21 | Eiry Roberts | Independent Director | Other Acquisition | +45,871 | -- |
| 2026-05-21 | Michael Goettler | Corporate Director | Other Acquisition | +45,871 | -- |
| 2026-05-21 | Frank Lee | Independent Director | Other Acquisition | +45,871 | -- |
| 2026-05-18 | Frank Lee | Independent Director | Automatic Disposition | -24,456 | $5.43 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 06:55:45 · For reference only, not investment advice and not tailored to your situation.